With the help of HLA class II predicted peptide megapools they demonstrated that all COVID-19 patients had robust viral spike glycoprotein (S) specific functional CD4+ T cell response that correlated with magnitude of SARS-CoV2 specific IgG and IgA titers. The gene discussed is CD4; the disease is COVID-19.